NCT00041483已完成3 期
Phase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of the Wet Form of AMD
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 530
- 试验地点
- 1
- 主要终点
- Percentage of Patients Maintaining Vision
研究概览
简要总结
The purpose of this study is to demonstrate that Anecortave Acetate is as effective after twelve months of treatment as photodynamic therapy (PDT) with Visudyne in patients eligible for initial PDT treatment for wet age-related macular degeneration.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 50 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Anecortave and Sham PDT
Active Comparator
干预措施: Anecortave Acetate 15 mg sterile suspension (Drug)
Anecortave and Sham PDT
Active Comparator
干预措施: Photodynamic Therapy (PDT) (Other)
PDT and Sham Anecortave Acetate
Active Comparator
干预措施: Anecortave Acetate 15 mg sterile suspension (Drug)
PDT and Sham Anecortave Acetate
Active Comparator
干预措施: Photodynamic Therapy (PDT) (Other)
结局指标
主要结局
Percentage of Patients Maintaining Vision
时间窗: Month 12
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
A Phase II Study of Anecortave Acetate for the Treatment of Exudative Age-Related Macular DegenerationAMDNCT00346957Alcon Research128
已完成
3 期
An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMDMaculopathy, Age-RelatedMacular DegenerationNCT00058994Alcon Research
已完成
3 期
Anecortave Acetate in Subfoveal Choroidal Neovascularization (CNV) Due to Wet Age-Related Macular Degeneration (AMD)Maculopathy, Age-RelatedAge-Related MaculopathiesAge-Related MaculopathyMaculopathies, Age-RelatedMacular DegenerationNCT00051129Alcon Research291
已完成
3 期
Anecortave Acetate in Patients With Exudative Age-related Macular Degeneration (AMD)Macular DegenerationNCT00299507Alcon Research240
终止
3 期
Anecortave Acetate Risk Reduction Trial (AART)AMDNCT00332657Alcon Research36